2m 2m 2m 2m 2m 2m 2m
JANUX THERAPEUTS (JANX)
NASDAQ
$17.49+$0.56 (+3.33%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.0BMarket Cap
- -35.73%1-Year Change
- BiotechnologyIndustry
JANUX THERAPEUTS (JANX)
$17.49+$0.56 (+3.33%)
JANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.93 | ||
Change | -$0.27 (-1.57%) | ||
Open | $17.22 | ||
High | $17.46 | ||
Low | $16.79 | ||
Previous Close | $17.20 | ||
Volume | 587,297 | ||
30-Day Average Volume | 831,559 | ||
1-Week Change | -1.17% | ||
1-Month Change | -0.47% | ||
1-Year Change | -35.73% | ||
3-Year Change | 150.81% | ||
5-Year Change | -32.33% | ||
Fundamentals | |||
Shares Outstanding | 61.1M | ||
Total Assets | $1.0B | ||
Market Cap | $1.0B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | $10.3M | ||
Net Income | -$22.0M | ||
Free Cash Flow | $12.3M | ||
EBIT | -$22.0M | ||
EBITDA | -$21.5M | ||
Net Working Capital | $923.2M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -47 | ||
Enterprise Value/Revenue | 98 | ||
P/B | 1 | ||
P/E | -48 | ||
PEG | -5 | ||
Price/Free Cash Flow | 84 | ||
Price/Operating Cash Flow | 83 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue